Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow

被引：0
|
作者：
Ulbrich, H
Eriksson, EE
Xie, X
Soehnlein, O
Lindbom, L
Laufer, S
Dannhardt, G
机构：
[1] Univ Mainz, Inst Pharm, Dept Pharmaceut & Med Chem, D-6500 Mainz, Germany
[2] Dept Physiol & Pharmacol, Stockholm, Sweden
[3] Univ Tubingen, Inst Pharm, Dept Pharmaceut & Med Chem, Tubingen, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 34 条
  • [21] Licofelone, A 5-LOX, COX-1 and COX-2 inhibitor, is as effective as celecoxib over 12 weeks of treatment: OARSI/OMERACT-OARSI response criteria results
    Buchner, A
    Bias, P
    Schulz, U
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 366 - 366
  • [22] Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa, a novel dual COX/5-LOX inhibitor
    Xu, Guang-Lin
    Liu, Fei
    Ao, Gui-Zhen
    He, Shu-Ying
    Ju, Min
    Zhao, Yue
    Xue, Ting
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 611 (1-3) : 100 - 106
  • [23] Licofelone, an inhibitor of COX-1, COX-2 and 5-LOX, has an excellent tolerability profile when given in single doses of up to 16-fold the therapeutic dose
    Bias, P
    Buchner, A
    Lammerich, A
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 479 - 479
  • [24] ZLJ-6, a Novel COX/5-LOX Inhibitor, Ameliorates Atherosclerosis by Reducing Macrophage Infiltration in ApoE-/- Mice
    Chen, Li
    Ji, Hui
    Lai, Yisheng
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (03): : 418 - 424
  • [25] RETRACTED ARTICLE: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
    Alessandra Bitto
    Letteria Minutoli
    Antonio David
    Natasha Irrera
    Mariagrazia Rinaldi
    Francesco S Venuti
    Francesco Squadrito
    Domenica Altavilla
    Critical Care, 16 (1):
  • [26] Retraction Note: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis
    Alessandra Bitto
    Letteria Minutoli
    Antonio David
    Natasha Irrera
    Mariagrazia Rinaldi
    Francesco S. Venuti
    Francesco Squadrito
    Domenica Altavilla
    Critical Care, 27
  • [27] ZLJ-6, a novel COX/5-LOX inhibitor, attenuates TNF-α-induced endothelial E-selectin, ICAM-1 and VCAM-1 expression and monocyte-endothelial interactions via a COX/5-LOX-independent mechanism
    Chen, Li
    Zhao, Qian
    Wang, Xu-Liang
    You, Ran
    Zhang, Yi-Hua
    Ji, Hui
    Lai, Yi-Sheng
    VASCULAR PHARMACOLOGY, 2011, 55 (5-6) : 135 - 142
  • [28] RETRACTED: Flavocoxid, a dual inhibitor of COX-2 and 5-LOX of natural origin, attenuates the inflammatory response and protects mice from sepsis (Retracted Article)
    Bitto, Alessandra
    Minutoli, Letteria
    David, Antonio
    Irrera, Natasha
    Rinaldi, Mariagrazia
    Venuti, Francesco S.
    Squadrito, Francesco
    Altavilla, Domenica
    CRITICAL CARE, 2012, 16 (01)
  • [29] Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade
    Tavolari, Simona
    Bonafe, Massimiliano
    Marini, Marina
    Ferreri, Carla
    Bartolini, Giovanna
    Brighenti, Elisa
    Manara, Sonia
    Tomasi, Vittorio
    Laufer, Stefan
    Guarnieri, Tiziana
    CARCINOGENESIS, 2008, 29 (02) : 371 - 380
  • [30] Twice the therapeutic dose of licofelone - An inhibitor of COX-1, COX-2 and 5-LOX - Results in a significantly lower GI ulcer incidence than naproxen in OA patients, when administered with or without concomitant low-dose aspirin
    Buchner, A
    Bias, P
    Lammerich, A
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 261 - 261
1234